For example, studies have suggested that CCR4 is significantly associated with the tumor microenvironment (TME) and prognosis in HNSCC [34,35], and that CCR4 may serve as a new potential molecular target for HNSCC therapy [36]. This evidence concerns the gene CCR4 and neoplasm.